4D Molecular Therapeutics, Inc. (FDMT) Revenue by Year
4D Molecular Therapeutics, Inc. generated $85.2M in revenue in fiscal year 2025. This represents an increase of 230194.6% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $92.0M in revenue. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters 4D Molecular Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
FDMT Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
FDMT Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More 4D Molecular Therapeutics, Inc. financials
Frequently Asked Questions
What was 4D Molecular Therapeutics, Inc.'s revenue in fiscal year 2025?
4D Molecular Therapeutics, Inc. generated $85.2M in revenue in fiscal year 2025.
How fast is 4D Molecular Therapeutics, Inc.'s revenue growing?
4D Molecular Therapeutics, Inc. (FDMT) revenue rose by 230194.6% year over year, from $37K to $85.2M in fiscal year 2025.
What is 4D Molecular Therapeutics, Inc.'s revenue over the last twelve months?
4D Molecular Therapeutics, Inc. (FDMT) reported $92.0M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has 4D Molecular Therapeutics, Inc.'s revenue changed over the years?
Across the 7 fiscal years this page covers, 4D Molecular Therapeutics, Inc. (FDMT) revenue went from $7.0M in fiscal year 2019 to $85.2M in fiscal year 2025.
What was 4D Molecular Therapeutics, Inc.'s revenue in the most recent quarter?
4D Molecular Therapeutics, Inc. (FDMT) reported $3.8M in revenue in Q2 2026. This represents an increase of 25106.7% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what 4D Molecular Therapeutics, Inc. (FDMT) reported on that line in every period on record.